The deficiency of CXCR6 or CXCR6-CXCL16 interaction leads to tumor proliferation [22, 23] and lower anti-tumor efficacy in tumor vaccination therapy, which is mainly based on TRM infiltration [24]. This evidence concerns the gene CXCR6 and neoplasm.